Results 171 to 180 of about 7,984 (250)

PDB24 LONG-TERM CLINICAL AND COST OUTCOMES OF TREATMENT WITH INSULIN DETEMIR PLUS INSULIN ASPART IN TYPE I DIABETES PATIENTS IN THE CZECH SETTING; DATA FROM THE PREDICTIVE STUDY

, 2008
JP Clegg, WJ Valentine, K Rychna, Marek Honka, Tomáš Doležal   +4 more
openalex   +1 more source

Antidiabetic drug utilization pattern, affordability and cost analysis in Iran from 2009 to 2021: A need to revise guideline. [PDF]

PLoS One
Zartab S, Abbasian H.
europepmc   +1 more source

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Abu Dhabi cohort of the A ₁ chieve study

, 2013
Oula Alhabian, Mowafaq Yehyia
openalex   +1 more source

PDB22 COST-EFFECTIVENESS OF INSULIN GLARGINE COMPARED TO INSULIN DETEMIR FOR TYPE 1 (T1DM) AND TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS IN THE CANADIAN PAYER SETTING

, 2008
ME Minshall, SL Tunis, Luc Sauriol
openalex   +1 more source

Addition of 20-kDa PEG to Insulin Lispro Alters Absorption and Decreases Clearance in Animals [PDF]

, 2016

core   +1 more source

A cost-utility analysis of long-acting insulin analogues (detemir, glargine and degludec) for the treatment of adult type 1 diabetes in South Africa. [PDF]

Cost Eff Resour Alloc
Verryn MT, Cleary S.
europepmc   +1 more source

Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake? [PDF]

Diabetes Obes Metab, 2015
Russell-Jones D, Danne T, Hermansen K, Niswender K, Robertson K, Thalange N, Vasselli JR, Yildiz B, Häring HU.   +8 more
europepmc   +1 more source

Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach. [PDF]

Diabetes Metab Syndr Obes, 2018
Pollock RF, Chubb B, Valentine WJ, Heller S.   +3 more
europepmc   +1 more source

Insulin detemir is not transported across the blood–brain barrier

, 2010
William A. Banks, John E. Morley, Jessica Lynch, Kristin M. Lynch, Arshag D. Mooradian   +4 more
openalex   +2 more sources

Using glucagon receptor antagonism to evaluate the physiological effects of extrapancreatic glucagon in totally pancreatectomised individuals: a randomised controlled trial. [PDF]

Diabetologia
Juel CT, Lund AB, Hædersdal S, Andersen MM, Hansen CP, Storkholm JH, van Hall G, Hartmann B, Rosenkilde MM, Kibsgaard CJ, Dela F, Albrechtsen NJW, Holst JJ, Vilsbøll T, Knop FK.   +14 more
europepmc   +1 more source